241 related articles for article (PubMed ID: 8277505)
1. Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.
Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
J Med Chem; 1993 Dec; 36(26):4230-8. PubMed ID: 8277505
[TBL] [Abstract][Full Text] [Related]
2. Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides.
Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
J Med Chem; 1993 Dec; 36(26):4239-49. PubMed ID: 8277506
[TBL] [Abstract][Full Text] [Related]
3. Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinity.
Ashton WT; Chang LL; Flanagan KL; Hutchins SM; Naylor EM; Chakravarty PK; Patchett AA; Greenlee WJ; Chen TB; Faust KA
J Med Chem; 1994 Aug; 37(17):2808-24. PubMed ID: 8064808
[TBL] [Abstract][Full Text] [Related]
4. The in vitro pharmacological profile of KR31080, a nonpeptide AT1 receptor antagonist.
Hong KW; Kim CD; Lee SH; Yoo SE
Fundam Clin Pharmacol; 1998; 12(1):64-9. PubMed ID: 9523186
[TBL] [Abstract][Full Text] [Related]
5. In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
Chang RS; Lotti VJ; Chen TB; O'Malley SS; Bendesky RJ; Kling PJ; Kivlighn SD; Siegl PK; Ondeyka D; Greenlee WJ
Eur J Pharmacol; 1995 Dec; 294(2-3):429-37. PubMed ID: 8750703
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
7. Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes.
Chang LL; Ashton WT; Flanagan KL; Chen TB; O'Malley SS; Zingaro GJ; Kivlighn SD; Siegl PK; Lotti VJ; Chang RS
J Med Chem; 1995 Sep; 38(19):3741-58. PubMed ID: 7562905
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates.
Ashton WT; Hutchins SM; Greenlee WJ; Doss GA; Chang RS; Lotti VJ; Faust KA; Chen TB; Zingaro GJ; Kivlighn SD
J Med Chem; 1993 Nov; 36(23):3595-605. PubMed ID: 8246227
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.
Briand V; Riva L; Galzin AM
Br J Pharmacol; 1994 Aug; 112(4):1195-201. PubMed ID: 7952881
[TBL] [Abstract][Full Text] [Related]
10. Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.
Ashton WT; Cantone CL; Chang LL; Hutchins SM; Strelitz RA; MacCoss M; Chang RS; Lotti VJ; Faust KA; Chen TB
J Med Chem; 1993 Mar; 36(5):591-609. PubMed ID: 8496939
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720).
Deprez P; Guillaume J; Becker R; Corbier A; Didierlaurent S; Fortin M; Frechet D; Hamon G; Heckmann B; Heitsch H
J Med Chem; 1995 Jun; 38(13):2357-77. PubMed ID: 7608902
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
Kivlighn SD; Zingaro GJ; Gabel RA; Broten TP; Chang RS; Ondeyka DL; Mantlo NB; Gibson RE; Greenlee WJ; Siegl PK
Eur J Pharmacol; 1995 Dec; 294(2-3):439-50. PubMed ID: 8750704
[TBL] [Abstract][Full Text] [Related]
13. Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.
Mederski WW; Dorsch D; Bokel HH; Beier N; Lues I; Schelling P
J Med Chem; 1994 May; 37(11):1632-45. PubMed ID: 8201597
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
15. EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypes.
Wong PC; Duncia JV; Santella JB; Smith RD; Wexler RR; Timmermans PB; Chiu AT
Eur J Pharmacol; 1994 Aug; 260(2-3):261-4. PubMed ID: 7988654
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
Cazaubon C; Gougat J; Bousquet F; Guiraudou P; Gayraud R; Lacour C; Roccon A; Galindo G; Barthelemy G; Gautret B
J Pharmacol Exp Ther; 1993 May; 265(2):826-34. PubMed ID: 8496828
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
19. Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypes.
Chang LL; Ashton WT; Flanagan KL; Chen TB; O'Malley SS; Zingaro GJ; Siegl PK; Kivlighn SD; Lotti VJ; Chang RS
J Med Chem; 1994 Dec; 37(26):4464-78. PubMed ID: 7799397
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A
Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
